<DOC>
	<DOC>NCT01414556</DOC>
	<brief_summary>Investigation of GIP effects at fasting and hypoglycemia</brief_summary>
	<brief_title>GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>Caucasians 18 years or older with Type 2 diabetes (WHO criteria) HbA1c &gt;9 % Liver disease (ALAT/ASAT &gt;2 x upper normal limit) Diabetic nephropathy (screatinine &gt;130 ÂµM or albuminuria) Proliferative diabetic retinopathy (anamnestic) Severe arteriosclerosis or heart failure (NYHA group III og IV) Anemia treatment with medication not applicable to pause for 12 hours Fasting plasma glucose &gt;15 mM on screening day.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>